Knight Therapeutics Stock
Your prediction
Knight Therapeutics Stock
There is an upward development for Knight Therapeutics compared to yesterday, with an increase of €0.060 (1.640%).
Pros and Cons of Knight Therapeutics in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 1.640% | 0.541% | -2.618% | 5.085% | 6.286% | 3.911% | 8.772% |
| Biomark Diagnostics Inc. | 0.000% | 6.667% | 48.454% | 126.772% | 164.220% | 159.459% | 286.577% |
| Avricore Health Inc. | - | 0.000% | 0.000% | -46.809% | -20.635% | -88.938% | -64.286% |
| MicroPlanet Technology Corp | - | 0.000% | -11.921% | 11.765% | 16.667% | -14.744% | 25.472% |
News
Executive Chairman Sells 35,000 Knight-Swift Transportation Shares for $1.8 Million. Is This a Cue to Something More Ominous?
Kevin P. Knight, Executive Chairman of Knight-Swift Transportation Holdings (NYSE:KNX), reported the indirect open-market sale of 35,000 shares for a transaction value of ~$1.8 million on Dec. 9
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces